Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Penn-Nicholson

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Plos One|August 22, 2020
Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysisHumphrey Mulenga, Chambrez-Zita Zauchenberger, Erick W Bunyasi, et al.
Ebiomedicine|July 19, 2022
Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscapeYohhei Hamada, Adam Penn-Nicholson, Sriram Krishnan, et al.
Vaccine|February 16, 2011
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisDanher Wang, Andreas Suhrbier, Adam Penn-Nicholson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2025
Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2023
Diagnostic accuracy of the NOVA Tuberculosis Total Antibody Rapid test for detection of pulmonary tuberculosis and infection with <i>Mycobacterium tuberculosis</i>Gideon Nsubuga, Samuel Kennedy, Yasha Rani, et al.
The Journal of Infectious Diseases|February 18, 2026
Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden settingHumphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
PLOS Global Public Health|June 5, 2026
Diagnostic accuracy study of the multiplex Truenat MTB Ultima/COVID-19 assay for simultaneous detection of Tuberculosis and SARS-CoV2 (COVID-19)Hafsah Tootla, Rita Székely, James Sserubiri, et al.
Tuberculosis (Edinburgh, Scotland)|March 2, 2021
Accuracy of the Truenat MTB-RIF Dx assay for detection of rifampicin resistance-associated mutationsSophia B Georghiou, Narayanan Sivaramakrishnan Gomathi, Priya Rajendran, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Plos One|August 22, 2020
Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysisHumphrey Mulenga, Chambrez-Zita Zauchenberger, Erick W Bunyasi, et al.
Ebiomedicine|July 19, 2022
Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscapeYohhei Hamada, Adam Penn-Nicholson, Sriram Krishnan, et al.
Vaccine|February 16, 2011
A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisDanher Wang, Andreas Suhrbier, Adam Penn-Nicholson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 24, 2025
Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysisCharl Bezuidenhout, Lawrence Long, Brooke Nichols, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|April 3, 2023
Diagnostic accuracy of the NOVA Tuberculosis Total Antibody Rapid test for detection of pulmonary tuberculosis and infection with <i>Mycobacterium tuberculosis</i>Gideon Nsubuga, Samuel Kennedy, Yasha Rani, et al.
The Journal of Infectious Diseases|February 18, 2026
Risk factors for immunological sensitization to Mycobacterium tuberculosis and progression to incident TB disease among HIV-uninfected adults in a high burden settingHumphrey Mulenga, Simon C Mendelsohn, Andrew Fiore-Gartland, et al.
Tuberculosis (Edinburgh, Scotland)|March 22, 2018
Considerations for biomarker-targeted intervention strategies for tuberculosis disease preventionAndrew Fiore-Gartland, Lindsay N Carpp, Kogieleum Naidoo, et al.
PLOS Global Public Health|June 5, 2026
Diagnostic accuracy study of the multiplex Truenat MTB Ultima/COVID-19 assay for simultaneous detection of Tuberculosis and SARS-CoV2 (COVID-19)Hafsah Tootla, Rita Székely, James Sserubiri, et al.
Tuberculosis (Edinburgh, Scotland)|March 2, 2021
Accuracy of the Truenat MTB-RIF Dx assay for detection of rifampicin resistance-associated mutationsSophia B Georghiou, Narayanan Sivaramakrishnan Gomathi, Priya Rajendran, et al.
Pageof 10